Enhancing Duloxetine With Mirogabalin for Treating Taxane-Induced Peripheral Neuropathy in Advanced Lung Cancer
Introduction Taxane-based cytotoxic anticancer drugs are a cornerstone of advanced lung cancer chemotherapy; however, they often result in chemotherapy-induced peripheral neuropathy (CIPN). Along with prolonged recovery, CIPN may cause irreversible damage. Consequently, dose reduction or discontinua...
Saved in:
| Main Authors: | Yasuhiro Nakajima MD, PhD, Kozo Kuribayashi MD, PhD, Akio Tada MD, PhD, Akichika Nagano MD, Toshiyuki Minami MD, PhD, Arihiko Kanehiro MD, PhD, Takashi Kijima MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748251353327 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal multi-omics identifies potential mechanisms driving taxane induced peripheral neuropathy
by: Anukriti Sharma, Ph.D., et al.
Published: (2025-07-01) -
Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma
by: Yumi Ishiyama, MD, et al.
Published: (2025-08-01) -
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01) -
Extended segmentectomy for intersegmental lesions with intraoperative surgical margin assessment by radiofrequency identification markersCentral MessagePerspective
by: Yojiro Yutaka, MD, PhD, et al.
Published: (2024-12-01) -
Outcomes of novel surgical procedures for graft size mismatch in living-donor lobar lung transplantationCentral Message
by: Daisuke Nakajima, MD, PhD, et al.
Published: (2020-09-01)